Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 81 | 101 | +20 |
| Shares | 8.80M | 13.3M | +4.52M (+51.4%) |
| Value | $111.5M | $108.4M | −$3.04M (−2.7%) |
New holders (29)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (9)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tang Capital Management LLC | 127,520 | $1.61M |
| HighVista Strategies LLC | 118,027 | $1.49M |
| Superstring Capital Management LP | 57,644 | $729.2K |
| Baker Avenue Asset Management, LP | 24,191 | $306.0K |
| Simplex Trading, LLC | 17,950 | $227.0K |
| Catalyst Funds Management Pty Ltd | 10,149 | $128.4K |
| Essential Partners LLC | 56 | $708 |
| IFP Advisors, Inc | 19 | $240 |
| Advisory Services Network, LLC | 14 | $177 |